HK1205147A1 - Truncated l1 proteins of human papillomavirus type 45 45 l1 - Google Patents

Truncated l1 proteins of human papillomavirus type 45 45 l1

Info

Publication number
HK1205147A1
HK1205147A1 HK15105714.7A HK15105714A HK1205147A1 HK 1205147 A1 HK1205147 A1 HK 1205147A1 HK 15105714 A HK15105714 A HK 15105714A HK 1205147 A1 HK1205147 A1 HK 1205147A1
Authority
HK
Hong Kong
Prior art keywords
truncated
proteins
human papillomavirus
papillomavirus type
type
Prior art date
Application number
HK15105714.7A
Other languages
Chinese (zh)
Inventor
李少偉
李智海
李韻冰
王大寧
魏旻希
張軍
夏寧邵
Original Assignee
Univ Xiamen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Xiamen filed Critical Univ Xiamen
Publication of HK1205147A1 publication Critical patent/HK1205147A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK15105714.7A 2013-06-04 2015-06-16 Truncated l1 proteins of human papillomavirus type 45 45 l1 HK1205147A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310217863.XA CN104211782B (en) 2013-06-04 2013-06-04 The type L1 albumen of HPV 45 of truncation

Publications (1)

Publication Number Publication Date
HK1205147A1 true HK1205147A1 (en) 2015-12-11

Family

ID=52093718

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15105714.7A HK1205147A1 (en) 2013-06-04 2015-06-16 Truncated l1 proteins of human papillomavirus type 45 45 l1

Country Status (2)

Country Link
CN (1) CN104211782B (en)
HK (1) HK1205147A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106701798B (en) * 2015-08-12 2021-09-17 北京康乐卫士生物技术股份有限公司 45 type recombinant human papilloma virus-like particle and preparation method thereof
US10513541B2 (en) * 2015-12-04 2019-12-24 Xiamen University Mutant of L1 protein of human papillomavirus type 11
CN115960178B (en) * 2022-12-28 2023-09-08 北京康乐卫士生物技术股份有限公司 Expression of human papilloma virus HPV59L1 protein, viroid particle and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0206360D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
CN1293093C (en) * 2002-08-30 2007-01-03 马润林 Pronucleus preparation of nipple tumour virus capsid protein and application
BRPI0815818A2 (en) * 2007-04-29 2016-08-02 Beijing Wantai Biological Pharmacy Entpr Co Ltd human papilloma virus type 18 truncated l1 protein
CN102229660B (en) * 2011-05-25 2015-04-22 厦门大学 Truncated human papillomavirus 33 type L1 protein

Also Published As

Publication number Publication date
CN104211782B (en) 2017-11-17
CN104211782A (en) 2014-12-17

Similar Documents

Publication Publication Date Title
IL276106A (en) Anti-garp protein and uses thereof
IL287516A (en) Therapeutic uses of empagliflozin
HRP20190101T1 (en) Therapeutic uses of empagliflozin
HK1220469A1 (en) Human antibodies to grem 1 grem1
HK1213818A1 (en) Therapeutic uses of empagliflozin
RS58097B1 (en) Therapeutic uses of empagliflozin
PT2986633T (en) Methods for the expression of peptides and proteins
HK1219961A1 (en) Human anti-ifn-alpha antibodies
HK1207879A1 (en) An optimized gene sequence encoding for the l1 protein of human papillomavirus type 31 31 l1
IL241418A0 (en) Title improved methods of use for recombinant human secretoglobins
HK1219962A1 (en) Human anti-il-32 antibodies -32
IL241417A0 (en) Modification and novel compositions of human secretoglobin proteins
HK1205147A1 (en) Truncated l1 proteins of human papillomavirus type 45 45 l1
EP2978770A4 (en) Refolding of proteins
GB201804143D0 (en) Human target II
GB201321911D0 (en) N-Glycosylation of peptides and proteins
GB201318313D0 (en) N-Glycosylation of peptides and proteins
GB201310748D0 (en) Student's clinic
GB201310101D0 (en) Treatment of freidreich's ataxia